{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:34:30Z","timestamp":1789706070111,"version":"4.0.1"},"reference-count":79,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Dipeptidyl peptidase 3 (DPP3) is a zinc-dependent aminopeptidase that is found in several places and is thought to be a cytosolic enzyme that helps break down peptides. Recent studies, however, have revealed its extensive therapeutic relevance upon release into circulation, functioning not only as a biomarker for cellular injury but also as an active modulator of cardiovascular homeostasis and critical disease. High levels of circulating DPP3 (cDPP3) have been linked to the causes of cardiogenic shock, septic shock, acute coronary syndromes, heart failure, and serious viral diseases like COVID-19. Its enzymatic breakdown of angiotensin II disrupts vascular tone and myocardial contractility, leading to hemodynamic instability and multi-organ failure. In numerous cohorts, cDPP3 levels reliably correspond with disease severity, acute renal damage, and death, but dynamic trajectories yield superior predictive information relative to single assessments. In addition to risk stratification, translational studies utilizing rodent and porcine models illustrate that antibody-mediated inhibition of cDPP3 with the humanized monoclonal antibody Procizumab reinstates cardiac function, stabilizes renal perfusion, diminishes oxidative stress and inflammation, and enhances survival. First-in-human experiences in patients with refractory septic cardiomyopathy have further emphasized its therapeutic promise. DPP3 is a good example of a biomarker and a mediator in cardiovascular and critical care. Its growing clinical and translational profile makes cDPP3 a strong predictor of bad outcomes and a prospective target for treatment. Ongoing clinical trials using Procizumab will determine if neutralizing cDPP3 can lead to enhanced outcomes in individuals with cardiogenic and septic shock. This review outlines the physiological mechanisms, clinical implications, and emerging therapeutic potential of DPP3 in cardiovascular and critical care. Ongoing trials with Procizumab will clarify whether neutralizing cDPP3 can improve outcomes in patients with cardiogenic and septic shock.<\/jats:p>","DOI":"10.3390\/jcm14217459","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:20:44Z","timestamp":1761196844000},"page":"7459","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["One Enzyme, Many Faces: The Expanding Role of DPP3 in Cardiovascular and Critical Care"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4444-0967","authenticated-orcid":false,"given":"Georgios E.","family":"Zakynthinos","sequence":"first","affiliation":[{"name":"3rd Department of Cardiology, \u201cSotiria\u201d Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos K.","family":"Kokkinos","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, \u201cSotiria\u201d Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna G.","family":"Tzima","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, \u201cSotiria\u201d Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6933-1068","authenticated-orcid":false,"given":"Ilias E.","family":"Dimeas","sequence":"additional","affiliation":[{"name":"School of Medicine, University College Dublin, D04 C1P1 Dublin, Ireland"},{"name":"Department of Respiratory Medicine, St. Vincent\u2019s University Hospital, D04 T6F4 Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1700-8244","authenticated-orcid":false,"given":"Ioannis","family":"Gialamas","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, \u201cSotiria\u201d Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gerostathis","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, \u201cSotiria\u201d Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Katsarou","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, \u201cSotiria\u201d Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Tsatsaragkou","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, \u201cSotiria\u201d Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2036-6192","authenticated-orcid":false,"given":"Konstantinos","family":"Kalogeras","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, \u201cSotiria\u201d Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-0599","authenticated-orcid":false,"given":"Evangelos","family":"Oikonomou","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, \u201cSotiria\u201d Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Siasos","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, \u201cSotiria\u201d Chest Diseases Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"},{"name":"Cardiovascular Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jshs.2020.10.005","article-title":"The association of grip strength with cardiovascular diseases and all-cause mortality in people with hypertension: Findings from the Prospective Urban Rural Epidemiology China Study","volume":"10","author":"Liu","year":"2021","journal-title":"J. Sport. Health Sci."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ye, P., Duan, W., Leng, Y.Q., Wang, Y.K., Tan, X., and Wang, W.Z. (2022). DPP3: From biomarker to therapeutic target of cardiovascular diseases. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.974035"},{"key":"ref_4","first-page":"937","article-title":"Hypertension Prevalence, Awareness, Treatment, and Control and Their Associated Socioeconomic Factors in China: A Spatial Analysis of A National Representative Survey","volume":"34","author":"Wang","year":"2021","journal-title":"Biomed. Environ. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5334\/gh.403","article-title":"Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: An Epidemiological Perspective","volume":"15","author":"Yuyun","year":"2020","journal-title":"Glob. Heart"},{"key":"ref_6","unstructured":"Georgoulias, P., Angelidis, G., Xanthopoulos, A., and Valotassiou, V. (Hell. J. Cardiol., 2025). Under pressure: Screening for heart failure in the elderly, Hell. J. Cardiol., online ahead of print."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1093\/eurheartj\/ehad568","article-title":"Circulating dipeptidyl peptidase 3: New hope for a specific treatment to improve prognosis in cardiogenic shock?","volume":"44","author":"Poss","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ventoulis, I., Verras, C., Matsiras, D., Bistola, V., Bezati, S., Parissis, J., and Polyzogopoulou, E. (2025). Bio-Adrenomedullin and Dipeptidyl Peptidase 3 as Novel Sepsis Biomarkers in the Emergency Department and the Intensive Care Unit: A Narrative Review. Medicina, 61.","DOI":"10.3390\/medicina61061059"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2174\/1389203718666170329104936","article-title":"Pathophysiological Implications of Dipeptidyl Peptidases","volume":"18","author":"Sato","year":"2017","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"22316","DOI":"10.1074\/jbc.M803522200","article-title":"The first structure of dipeptidyl-peptidase III provides insight into the catalytic mechanism and mode of substrate binding","volume":"283","author":"Baral","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1515\/BC.1999.182","article-title":"Dipeptidyl peptidase III from rat liver cytosol: Purification, molecular cloning and immunohistochemical localization","volume":"380","author":"Ohkubo","year":"1999","journal-title":"Biol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1046\/j.1471-4159.1994.63041439.x","article-title":"Dipeptidyl aminopeptidase III of guinea-pig brain: Specificity for short oligopeptide sequences","volume":"63","author":"Smyth","year":"1994","journal-title":"J. Neurochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1111\/febs.16429","article-title":"The emerging role of dipeptidyl peptidase 3 in pathophysiology","volume":"290","author":"Malovan","year":"2023","journal-title":"FEBS J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/clinchem\/hvae058","article-title":"DPP3 in Cardiogenic Shock","volume":"70","author":"Jaffe","year":"2024","journal-title":"Clin. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13054-025-05545-x","article-title":"Targeting high circulating dipeptidyl peptidase 3 in circulatory failure","volume":"29","author":"Picod","year":"2025","journal-title":"Crit. Care"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock\u2014A position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Chioncel","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021","volume":"79","author":"Naidu","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jchf.2020.09.005","article-title":"A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock","volume":"8","author":"Tehrani","year":"2020","journal-title":"JACC Heart Fail."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ejhf.3531","article-title":"Current and novel biomarkers in cardiogenic shock","volume":"27","author":"Galusko","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e007293","DOI":"10.1161\/CIRCINTERVENTIONS.118.007293","article-title":"Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry","volume":"12","author":"Hunziker","year":"2019","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Karamasis, G.V., Polyzogopoulou, E., Varlamos, C., Frantzeskaki, F., Dragona, V.M., Boultadakis, A., Bistola, V., Fountoulaki, K., Pappas, C., and Kolokathis, F. (2024). Implementation of a cardiogenic shock team in a tertiary academic center. Hell. J. Cardiol., in press.","DOI":"10.1016\/j.hjc.2024.06.011"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0006-291X(83)80191-0","article-title":"Purification and characterization of enkephalin-degradating enzymes from calf-brain striatum","volume":"115","author":"Soudijn","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s40618-014-0217-z","article-title":"The effect of 17beta-estradiol on the expression of dipeptidyl peptidase III and heme oxygenase 1 in liver of CBA\/H mice","volume":"38","author":"Sobocanec","year":"2015","journal-title":"J. Endocrinol. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.redox.2016.01.003","article-title":"Prominent role of exopeptidase DPP III in estrogen-mediated protection against hyperoxia in vivo","volume":"8","author":"Sobocanec","year":"2016","journal-title":"Redox Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.peptides.2016.06.005","article-title":"Identification of dipeptidyl peptidase 3 as the Angiotensin-(1-7) degrading peptidase in human HK-2 renal epithelial cells","volume":"83","author":"Wilson","year":"2016","journal-title":"Peptides"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Renin-angiotensin system revisited","volume":"264","author":"Fyhrquist","year":"2008","journal-title":"J. Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1373\/jalm.2018.027995","article-title":"Novel Methods for the Quantification of Dipeptidyl Peptidase 3 (DPP3) Concentration and Activity in Human Blood Samples","volume":"3","author":"Rehfeld","year":"2019","journal-title":"J. Appl. Lab. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13054-021-03471-2","article-title":"Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: A prospective observational multinational study","volume":"25","author":"Blet","year":"2021","journal-title":"Crit. Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13711","DOI":"10.1074\/jbc.RA120.014183","article-title":"Dipeptidyl peptidase 3 modulates the renin-angiotensin system in mice","volume":"295","author":"Jha","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1164\/rccm.202010-3873LE","article-title":"Alteration of the Renin-Angiotensin-Aldosterone System in Shock: Role of the Dipeptidyl Peptidase 3","volume":"203","author":"Picod","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13054-020-2733-x","article-title":"Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock","volume":"24","author":"Bellomo","year":"2020","journal-title":"Crit. Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/BJ20061738","article-title":"Lysosomes and Fas-mediated liver cell death","volume":"403","author":"Wattiaux","year":"2007","journal-title":"Biochem. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1083\/jcb.151.6.1247","article-title":"Necrotic death pathway in Fas receptor signaling","volume":"151","author":"Matsumura","year":"2000","journal-title":"J. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1083\/jcb.143.5.1353","article-title":"Caspase-independent cell killing by Fas-associated protein with death domain","volume":"143","author":"Kawahara","year":"1998","journal-title":"J. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/joim.13220","article-title":"Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3","volume":"289","author":"Kox","year":"2021","journal-title":"J. Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/jbmr.3829","article-title":"Absence of Dipeptidyl Peptidase 3 Increases Oxidative Stress and Causes Bone Loss","volume":"34","author":"Menale","year":"2019","journal-title":"J. Bone Min. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"107595","DOI":"10.1016\/j.intimp.2021.107595","article-title":"Dipeptidyl-peptidase 3 protects oxygen-glucose deprivation\/reoxygenation-injured hippocampal neurons by suppressing apoptosis, oxidative stress and inflammation via modulation of Keap1\/Nrf2 signaling","volume":"96","author":"Ren","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1111\/j.1742-4658.2011.08275.x","article-title":"Dipeptidyl peptidase III: A multifaceted oligopeptide N-end cutter","volume":"278","author":"Prajapati","year":"2011","journal-title":"FEBS J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1073\/pnas.0700898104","article-title":"A genomic screen for activators of the antioxidant response element","volume":"104","author":"Liu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Matic, S., Tomasic Paic, A., Sobocanec, S., Pinteric, M., Pipalovic, G., Martincic, M., Matovina, M., and Tomic, S. (2022). Interdisciplinary Study of the Effects of Dipeptidyl-Peptidase III Cancer Mutations on the KEAP1-NRF2 Signaling Pathway. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23041994"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12551-016-0244-4","article-title":"The Keap1-Nrf2 pathway: Promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases","volume":"9","author":"Deshmukh","year":"2017","journal-title":"Biophys. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.14336\/AD.2018.0513","article-title":"The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1\/Nrf2\/ARE Signaling Pathway in Chronic Diseases","volume":"10","author":"Tu","year":"2019","journal-title":"Aging Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.intimp.2013.09.009","article-title":"Quercetin inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglial cells by suppressing the NF-kappaB pathway and activating the Nrf2-dependent HO-1 pathway","volume":"17","author":"Kang","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Taguchi, K., and Yamamoto, M. (2017). The KEAP1-NRF2 System in Cancer. Front. Oncol., 7.","DOI":"10.3389\/fonc.2017.00085"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1158\/0008-5472.CAN-16-2204","article-title":"NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-KEAP1 Interaction","volume":"77","author":"Lu","year":"2017","journal-title":"Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/bbrc.2000.2827","article-title":"Identification of dipeptidyl peptidase III in human neutrophils","volume":"273","author":"Hashimoto","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0020-711X(91)90116-5","article-title":"Types and localization of aminopeptidases in different human blood cells","volume":"23","author":"Grdisa","year":"1991","journal-title":"Int. J. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/IAI.01263-13","article-title":"Host-pathogen interaction and signaling molecule secretion are modified in the dpp3 knockout mutant of Candida lusitaniae","volume":"82","author":"Sabra","year":"2014","journal-title":"Infect. Immun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0959-8049(97)00401-2","article-title":"Dipeptidyl peptidase III in malignant and non-malignant gynaecological tissue","volume":"34","author":"Simaga","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Choy, T.K., Wang, C.Y., Phan, N.N., Khoa Ta, H.D., Anuraga, G., Liu, Y.H., Wu, Y.F., Lee, K.H., Chuang, J.Y., and Kao, T.J. (2021). Identification of Dipeptidyl Peptidase (DPP) Family Genes in Clinical Breast Cancer Patients via an Integrated Bioinformatics Approach. Diagnostics, 11.","DOI":"10.3390\/diagnostics11071204"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41419-021-03796-4","article-title":"DPP3\/CDK1 contributes to the progression of colorectal cancer through regulating cell proliferation, cell apoptosis, and cell migration","volume":"12","author":"Tong","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-12-4400","article-title":"Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination","volume":"73","author":"Hast","year":"2013","journal-title":"Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Kaufmann, P., Muenzner, M., Kastorf, M., Santos, K., Hartmann, T., Dienelt, A., Rehfeld, L., and Bergmann, A. (2019). A novel and highly efficient purification procedure for native human dipeptidyl peptidase 3 from human blood cell lysate. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220866"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ejhf.1601","article-title":"Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: Dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics","volume":"22","author":"Deniau","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40635-024-00638-3","article-title":"Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury","volume":"12","author":"Garcia","year":"2024","journal-title":"Intensive Care Med. Exp."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.116.07357","article-title":"Novel Therapeutic Role for Dipeptidyl Peptidase III in the Treatment of Hypertension","volume":"68","author":"Pang","year":"2016","journal-title":"Hypertension"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Komeno, M., Pang, X., Shimizu, A., Molla, M.R., Yasuda-Yamahara, M., Kume, S., Rahman, N.I.A., Soh, J.E.C., Nguyen, L.K.C., and Ahmat Amin, M.K.B. (2021). Cardio- and reno-protective effects of dipeptidyl peptidase III in diabetic mice. J. Biol. Chem., 296.","DOI":"10.1016\/j.jbc.2021.100761"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ejhf.2158","article-title":"Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure","volume":"23","author":"Boorsma","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/joim.13449","article-title":"Circulating dipeptidyl peptidase (cDPP3)-A marker for end-stage heart failure?","volume":"291","author":"Pavo","year":"2022","journal-title":"J. Intern. Med."},{"key":"ref_62","first-page":"185","article-title":"Circulating dipeptidyl peptidase 3 modulates hemodynamics and the renin-angiotensin-aldosterone system in mice","volume":"14","author":"Picod","year":"2022","journal-title":"Arch. Cardiovasc. Dis. Suppl."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/HYPERTENSIONAHA.116.07471","article-title":"On Endogenous Angiotensin II Antagonism in Hypertension: The Role of Dipeptidyl Peptidase III","volume":"68","author":"Ocaranza","year":"2016","journal-title":"Hypertension"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"10760296221145174","DOI":"10.1177\/10760296221145174","article-title":"A Novel Indicator of Myocardial Injury after Acute Myocardial Infarction: \u2018DPP-3\u2019","volume":"28","author":"Ozden","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/eurheartj\/ehad545","article-title":"Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes","volume":"44","author":"Wenzl","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ejhf.1600","article-title":"Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: Results from the OptimaCC trial","volume":"22","author":"Takagi","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Innelli, P., Lopizzo, T., Paterno, G., Bruno, N., Radice, R.P., Bertini, P., Marabotti, A., Luzi, G., Stabile, E., and Di Fazio, A. (2023). Dipeptidyl Amino-Peptidase 3 (DPP3) as an Early Marker of Severity in a Patient Population with Cardiogenic Shock. Diagnostics, 13.","DOI":"10.3390\/diagnostics13071350"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cardfail.2024.03.014","article-title":"High Circulating Dipeptidyl Peptidase 3 Predicts Mortality and Need for Organ Support in Cardiogenic Shock: An Ancillary Analysis of the ACCOST-HH Trial","volume":"31","author":"Picod","year":"2025","journal-title":"J. Card. Fail."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"154383","DOI":"10.1016\/j.jcrc.2023.154383","article-title":"Associations of dipeptidyl-peptidase 3 with short-term outcome in a mixed admission ICU-cohort","volume":"78","author":"Beunders","year":"2023","journal-title":"J. Crit. Care"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s13054-025-05578-2","article-title":"Value of cDPP3 as a short-term prognostic biomarker in all-comers critically ill patients in the emergency department","volume":"29","author":"Fidelio","year":"2025","journal-title":"Crit. Care"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.bja.2021.11.021","article-title":"High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: Results from the international, prospective and observational FROG-ICU cohort","volume":"128","author":"Deniau","year":"2022","journal-title":"Br. J. Anaesth."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20242168","article-title":"Higher circulating ACE2 and DPP3 but reduced ACE and angiotensinogen in hyperreninemic sepsis patients","volume":"139","author":"Chappell","year":"2025","journal-title":"Clin. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13063-024-07995-0","article-title":"The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: Serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock","volume":"25","author":"Teixeira","year":"2024","journal-title":"Trials"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"154950","DOI":"10.1016\/j.jcrc.2024.154950","article-title":"Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19","volume":"85","author":"Busse","year":"2025","journal-title":"J. Crit. Care"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"00342-2022","DOI":"10.1183\/23120541.00342-2022","article-title":"Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: A prospective international multicentre study","volume":"9","author":"Deniau","year":"2023","journal-title":"ERJ Open Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13054-025-05439-y","article-title":"Biomarkers in acute kidney injury settings to predict interventions and outcomes: The MARKISIO study","volume":"29","author":"Chaibi","year":"2025","journal-title":"Crit. Care"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Deniau, B., Blet, A., Santos, K., Vaittinada Ayar, P., Genest, M., Kastorf, M., Sadoune, M., de Sousa Jorge, A., Samuel, J.L., and Vodovar, N. (2020). Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: A proof of concept study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0238039"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ejhf.1649","article-title":"Dipeptidyl peptidase 3, a biomarker in cardiogenic shock and hopefully much more","volume":"22","author":"Magliocca","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/ejhf.3718","article-title":"Targeting dipeptidyl peptidase 3 (DPP3) in extreme-critically ill patients with refractory shock: First-in-human report on the safety and efficacy of an anti-DPP3 antibody","volume":"27","author":"Jarczak","year":"2025","journal-title":"Eur. J. Heart Fail."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/21\/7459\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:52:34Z","timestamp":1761198754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/21\/7459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":79,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["jcm14217459"],"URL":"https:\/\/doi.org\/10.3390\/jcm14217459","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}